U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06825741) titled 'Brain Structural Abnormalities in Patients with Post-COVID-19 Headache' on Feb. 11.
Brief Summary: Introduction: The clinical manifestations of the COVID-19 pandemic are heterogeneous and may include various symptoms (gastrointestinal, musculoskeletal, neurological). Approximately 25% of patients report headache as a neurological symptom, making it the fifth most common symptom. These headaches may arise from structural brain changes associated with the infection.
Purpose: This study aims to identify the structural abnormalities observed in brain MRI that correlate with chronic headaches in patients who had COVID-19 infection.
Met...